PG
BIO icon

PEAK6 Group’s Bio-Rad Laboratories Class A BIO Stock Holding History

PEAK6 Group’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-1,000
Closed -$250K – 4328
2018
Q1 		$250K Sell
1,000
-500
-33% -$127K ﹤0.01% 3188
2017
Q4 		$358K Buy
1,500
+300
+25% +$72.7K ﹤0.01% 2737
2017
Q3 		$267K Buy
+1,200
New +$270K ﹤0.01% 3055
2016
Q3 		– Sell
-400
Closed -$57K – 4308
2016
Q2 		$57K Buy
+400
New +$57.1K ﹤0.01% 3808
2015
Q3 		– Sell
-6,200
Closed -$934K – 5117
2015
Q2 		$934K Buy
+6,200
New +$887K 0.01% 2157

Other funds holding BIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PEAK6 Group's BIO Position: Q2 2018 in Review

PEAK6 Group sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2018, closing a stake of 500 shares — an estimated $138K sold.

PEAK6 Group first reported a position in BIO in Q3 2015 and held it in 8 quarters. The position peaked at $1.02M in Q4 2016. 326 funds tracked by Wall St. Rank hold BIO as of Q2 2018.

  • PEAK6 Group reported no remaining Bio-Rad Laboratories Class A position as of Q2 2018 after selling out during the quarter.
  • PEAK6 Group sold 500 Bio-Rad Laboratories Class A shares in Q2 2018, an estimated $138K.
  • PEAK6 Group first reported a position in Bio-Rad Laboratories Class A in Q3 2015 and held it in 8 quarters.
  • PEAK6 Group's Bio-Rad Laboratories Class A position peaked at $1.02M in Q4 2016.
  • 326 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.